HBIO
TechnologyHarvard Bioscience Inc
Live · NASDAQ · May 9, Close
What's Moving HBIO Today?
No stock-specific AI insight has been generated for HBIO yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
HBIO News
20 articles- Harvard Bioscience to Participate in Upcoming Investor ConferencesYahoo Finance·May 7, 2026
- Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ETYahoo Finance·Apr 28, 2026
- How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 ExpectationsYahoo Finance·Mar 16, 2026
- Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: Strong Operational Efficiency ...Yahoo Finance·Mar 12, 2026
- Harvard Bioscience, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 12, 2026
- Harvard Bioscience (HBIO) Earnings TranscriptMotley Fool·Mar 12, 2026
- Harvard Bioscience: Q4 Earnings SnapshotYahoo Finance·Mar 12, 2026
- Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial ResultsYahoo Finance·Mar 12, 2026
- Harvard Bioscience Announces Reverse Stock SplitYahoo Finance·Mar 6, 2026
- Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare ForumYahoo Finance·Mar 3, 2026
- Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ETYahoo Finance·Feb 26, 2026
- Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus AreasYahoo Finance·Feb 10, 2026
- Harvard Bioscience will move Holliston MA manufacturing out of stateMetrowestdailynews·Feb 3, 2026
- Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term GrowthYahoo Finance·Jan 29, 2026
- Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing PackageYahoo Finance·Dec 17, 2025
- Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest ReportYahoo Finance·Nov 9, 2025
- Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)?Yahoo Finance·Nov 7, 2025
- Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Highlights: Strong Margins and Strategic ...Yahoo Finance·Nov 6, 2025
- Harvard Bioscience: Q3 Earnings SnapshotYahoo Finance·Nov 6, 2025
- Harvard Bioscience Announces Third Quarter 2025 Financial ResultsYahoo Finance·Nov 6, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About Harvard Bioscience Inc
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.